Page last updated: 2024-09-03

4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline and Acquired-Immune Deficiency Syndrome Dementia Complex

4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hutson, PH; Reynolds, GP; Sardar, AM1

Other Studies

1 other study(ies) available for 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline and Acquired-Immune Deficiency Syndrome Dementia Complex

ArticleYear
Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS.
    Neuroreport, 1999, Nov-26, Volume: 10, Issue:17

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Aminoquinolines; Aspartic Acid; Binding Sites; Excitatory Amino Acid Antagonists; Frontal Lobe; Glutamic Acid; Humans; Kinetics; Matched-Pair Analysis; Receptors, N-Methyl-D-Aspartate; Thermodynamics

1999